BVS
Bioventus Inc.
BVS has the edge over UNH overall, supported by stronger fundamentals and stronger valuation.
UNH
UnitedHealth Group Incorporated
UNH has lower modeled downside risk, despite its lower overall score.
BVS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
BVS's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
BVS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $10.86 | — |
| Current | 14x | $10.86 | — |
| Cheap | 18x | $14.37 | +32% |
| Fair | 26x | $21.13 | +95% |
| Expensive | 69x | $54.91 | +406% |
Historical ranges are pointers, not guarantees.
BVS has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BVS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BVS, with profitability improving.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BVS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.81 | +1.6% |
| Q3 2026 | $0.80 | +627% |
| Q2 2026 | $0.77 | +$0.78 |
| Q1 2026 | $0.41 | +$0.90 |
| Q4 2025 | $0.33 | +$0.85 |
| Q3 2025 | $0.11 | +$0.69 |
| Q2 2025 | -$0.01 | +$0.62 |
| Q1 2025 | -$0.49 | -$0.17 |
| Q4 2024 | -$0.52 | +$1.97 |
BVS has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
BVS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $142.4M | +2.7% |
| Q2 2026 | $153.2M | +3.8% |
| Q1 2026 | $132.1M | +6.6% |
| Q4 2025 | $157.9M | +2.8% |
| Q3 2025 | $138.7M | -0.2% |
| Q2 2025 | $147.7M | -2.4% |
| Q1 2025 | $123.9M | -4.3% |
| Q4 2024 | $153.6M | +13% |
BVS's revenue grew through 2024 and has held roughly level since: $142M last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.8% | -1.3 points |
| Q2 2026 | 12% | 0 points |
| Q1 2026 | 6.4% | +2.4 points |
| Q4 2025 | 12% | +7.1 points |
| Q3 2025 | 8.1% | +5.2 points |
| Q2 2025 | 12% | +32 points |
| Q1 2025 | 3.9% | -0.2 points |
| Q4 2024 | 5.2% | +4.3 points |
BVS has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over BVS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
BVS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $20.3M | -31% |
| Q2 2026 | $18.9M | -25% |
| Q1 2026 | $8.4M | +$28.5M |
| Q4 2025 | $37.4M | +99% |
| Q3 2025 | $29.6M | +189% |
| Q2 2025 | $25.3M | +67% |
| Q1 2025 | -$20.2M | -$13.9M |
| Q4 2024 | $18.7M | +87% |
BVS generated $85M in free cash flow over the past year, up 59% from the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
BVS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.3% | +1.7M shares |
| 1 year | +5.3% | +3.7M shares |
| 3 years | +15% | +9.7M shares |
| 5 years | +73% | +30.7M shares |
| Available history | +30% | +16.9M shares |
BVS has 72M diluted shares, up 5.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over BVS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
BVS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 4.0x | High |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 20.2x | High |
| Q4 2024 | 18.0x | High |
BVS's net debt is about 2.4 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over BVS on leverage, with a lower net debt burden relative to earnings.
BVS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 19.8 | Oversold |
BVS's weekly RSI is 44 (neutral) and its Stochastic is 20 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
BVS PE vs Healthcare Sector
| Metric | BVS | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 26x | 48% below |
| PE % | 2 | 35 | 33 pts below |
BVS has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
BVS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.9 | 16% below |
| 20 week MA | $13.0 | 16% below |
| 50 week MA | $10.4 | 4.4% above |
| 100 week MA | $9.16 | 19% above |
| 200 week MA | $7.20 | 51% above |
BVS has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 51% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over BVS on trend strength, trading above more of its moving averages.
BVS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $17.2 | $14.0 | -19% |
| 2022 | $14.0 | $2.54 | -82% |
| 2023 | $2.54 | $5.27 | +107% |
| 2024 | $5.27 | $10.6 | +102% |
| 2025 | $10.6 | $7.46 | -30% |
| 2026 YTD | $7.46 | $10.9 | +46% |
BVS has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.